Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,078.00
-38.50 (-0.63%)
Apr 13, 2026, 3:30 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.62 trillion as of April 13, 2026. Its market cap has increased by 5.13% in one year.
Market Cap
1.62T
Enterprise Value
1.59T
Revenue
103.14B
Ranking
n/a
PE Ratio
65.51
Stock Price
6,078.00
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.62T, an increase of 79,670.37%. That is a compound annual growth rate of 33.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 1.62T | -4.32% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3.97T |
| Cipla | 993.17B |
| Zydus Lifesciences | 921.11B |
| Mankind Pharma | 858.27B |
| Aurobindo Pharma | 783.73B |
| Alkem Laboratories | 650.43B |
| Glenmark Pharmaceuticals | 610.46B |
| Laurus Labs | 592.95B |